Human Papillomavirus Infection and Cervical Cancer Prevention in Japan and Korea

Human Papillomavirus Genotypes and Cervical Cancer in Northeast Thailand

“…HPV-58 is not rare in Asian women with normal cervical cytology; its prevalence being <1% in Thailand, Vietnam, Japan and Korea (Domingo et al, 2008;Konno et al, 2008) and 1~2% in Taiwan and China (Shi et al, 2008;Tay et al, 2008). Among SCCA patients, a condensation of HPV-58 infection (about 26%) was reported in Shanghai (Huang et al, 1997), whereas it reached 18% in Khon Kaen (present study; Sriamporn et al, 2006).…”

Cost-Effectiveness of Korea's National Cervical Cancer Screening Program

“…Recently, the prevalence of human papillomavirus (HPV) infection has increased in Korea, resulting in a continued, high burden of cervical cancer (Konno et al, 2008). Although two HPV vaccines are available in Korea, the cost of including them in the National Immunization program is prohibitive.…”

“…For this reason, continuous efforts to expand participation in cervical cancer screening are still required. Increasing the uptake of cervical cancer screening is especially important because even though the ICER of adding vaccination to the Pap smear screening would be an cost-effective option, women of low socioeconomic status are less likely to participate in screening or to be able to afford the vaccination (Konno et al, 2008;Park et al, 2011;Praditsitthikorn et al, 2011;Yamamoto et al, 2012). The cost-effectiveness of vaccination in combination with frequent or infrequent screening by the NCSP needs to be evaluated, in light of young women's low screening participation rate and :http://dx.doi.org/10.7314/APJCP.2013.14.7.4329 Cost-Effectiveness of Cervical Cancer Screening Recently, the HPV-DNA screening test has attracted public attention, especially in developing countries, as a potentially more cost-effective alternative to the Pap smear (Levin et al, 2010;Flores et al, 2011).…”

“…It is one of the most common cancers in developing countries, and it also represents a major health issue in Korea and Japan, economically developed Asian nations (Konno et al, 2008;Razak et al, 2013). In Korea, cervical cancer accounted for 9.8% of new cancer cases in 2002, although the age-standardized incidence has steadily declined from 19 per 100,000 women in 1993-1995 to 15 per 100,000 women in 1999-2002(Chung et al, 2006Shin et al, 2007).…”

“…In Japan, the Papanicolaou (Pap) smear, the conventional cytological method for cervical cancer mass screening, is used in an organized cervical cancer screening program (Konno et al, 2008). In Korea, a National Cancer Screening Program (NCSP) including the Pap smear was established in 1999, and, since 2002, coverage has included all National Health Insurance (NHI) beneficiaries and Medical Aid recipients (Cho et al, 2013).…”